Cargando…
Respiratory syncytial virus entry and how to block it
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract disease in young children and elderly people. Although the virus was isolated in 1955, an effective RSV vaccine has not been developed, and the only licensed intervention is passive immunoprophylaxis of high-risk infants...
Autores principales: | Battles, Michael B., McLellan, Jason S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096974/ https://www.ncbi.nlm.nih.gov/pubmed/30723301 http://dx.doi.org/10.1038/s41579-019-0149-x |
Ejemplares similares
-
Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein
por: Tian, Daiyin, et al.
Publicado: (2017) -
Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor
por: Roymans, Dirk, et al.
Publicado: (2017) -
Respiratory Syncytial Virus Entry Inhibitors Targeting the F Protein
por: Sun, Zhiwu, et al.
Publicado: (2013) -
Structure of the Respiratory Syncytial Virus Polymerase Complex
por: Gilman, Morgan S.A., et al.
Publicado: (2019) -
Distinctive features of the respiratory syncytial virus priming loop compared to other non-segmented negative strand RNA viruses
por: Cressey, Tessa N., et al.
Publicado: (2022)